glp-1 trade names What are the commercial (brand) of GLP‑1 receptor agonist medications? Glucagon-like peptide-1 - Wikipedia

Unsurprisingly, stepping into the political space hasnt been smooth sailing

polyethylene glycol (Miralax) is often recommended as a first-line option

Metabolic Regulation: Researching the secondary effects of isolated growth hormone release on lipid metabolism and nutrient partitioning

If passed, TROA would: Permanently allow Medicare Part D to cover FDA-approved anti-obesity medications Expand Medicare Part B coverage of intensive behavioral therapy for obesity to include a wider range of providers (not just primary care physicians) However, in April 2025, CMS announced it would not include Medicare Part D coverage of obesity drugs in its rule changes for 2026, stating the proposal was "not appropriate at this time." That decision pushed the issue back to Congress, where the TROA remains under consideration